Overview
Sander Kneepkens practices practicing medicine in Rotterdam, Netherlands.
Mr. Kneepkens is highly rated in 1 condition, according to our data. His clinical expertise encompasses Nearsightedness and Stargardt Macular Degeneration.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sander M. Kneepkens
Is Sander M. Kneepkens a top-rated expert for Nearsightedness?
MediFind is an objective health platform that identifies experts based on real-world data. Sander M. Kneepkens is classified as an Advanced expert for Nearsightedness, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sander M. Kneepkens participate in research or clinical trials?
Yes. Sander M. Kneepkens has published 9 articles and abstracts on conditions like Nearsightedness. You can view a list of Sander M. Kneepkens's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- NearsightednessMr. Kneepkens isAdvanced. Learn about Nearsightedness.
- Experienced
- Stargardt Macular DegenerationMr. Kneepkens isExperienced. Learn about Stargardt Macular Degeneration.